William Plovanic | Chief Financial Officer |
Andrew Rasdal | President and Chief Executive Officer |
Rick Wise | Stifel, Nicolaus & Company |
Ryan Zimmerman | BTIG |
Brandon Vazquez | Canaccord Genuity Inc. |
Good day, ladies and gentlemen, and welcome to the Obalon Therapeutics’ First Quarter 2018 Financial Results Conference Call.
As a reminder, this conference call is being recorded. I would now like to turn the conference over to Mr. Bill Plovanic, Chief Financial Officer of Obalon.
You may begin.